49,700 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Acquired by Louisiana State Employees Retirement System

Louisiana State Employees Retirement System purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 49,700 shares of the company’s stock, valued at approximately $1,674,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Mutual of America Capital Management LLC increased its position in Option Care Health by 63.3% during the fourth quarter. Mutual of America Capital Management LLC now owns 190,684 shares of the company’s stock worth $6,424,000 after purchasing an additional 73,938 shares during the last quarter. Wellington Management Group LLP increased its position in Option Care Health by 15.9% during the third quarter. Wellington Management Group LLP now owns 2,896,392 shares of the company’s stock worth $93,698,000 after purchasing an additional 397,627 shares during the last quarter. Ontario Teachers Pension Plan Board acquired a new position in Option Care Health during the third quarter worth approximately $546,000. Van ECK Associates Corp increased its position in Option Care Health by 244.2% during the third quarter. Van ECK Associates Corp now owns 34,291 shares of the company’s stock worth $1,109,000 after purchasing an additional 24,328 shares during the last quarter. Finally, Graham Capital Management L.P. acquired a new position in Option Care Health during the third quarter worth approximately $2,816,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Insider Activity at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of the stock in a transaction that occurred on Monday, February 26th. The stock was acquired at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the acquisition, the director now owns 269,528 shares in the company, valued at $8,503,608.40. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 0.64% of the company’s stock.

Option Care Health Price Performance

Option Care Health stock opened at $31.08 on Friday. Option Care Health, Inc. has a 52-week low of $24.23 and a 52-week high of $35.74. The firm has a fifty day moving average of $32.27 and a 200-day moving average of $31.57. The firm has a market capitalization of $5.40 billion, a P/E ratio of 21.14, a PEG ratio of 1.76 and a beta of 1.22. The company has a quick ratio of 1.33, a current ratio of 1.77 and a debt-to-equity ratio of 0.74.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Thursday, February 22nd. The company reported $0.32 earnings per share for the quarter, beating analysts’ consensus estimates of $0.29 by $0.03. The business had revenue of $1.12 billion during the quarter, compared to analyst estimates of $1.09 billion. Option Care Health had a net margin of 6.21% and a return on equity of 18.78%. The business’s revenue was up 9.5% on a year-over-year basis. During the same period last year, the business earned $0.26 EPS. As a group, analysts predict that Option Care Health, Inc. will post 1.13 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on OPCH shares. Barrington Research increased their price objective on shares of Option Care Health from $35.00 to $38.00 and gave the stock an “outperform” rating in a research report on Friday, February 23rd. Jefferies Financial Group increased their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a research report on Monday, March 4th.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.